(Q28373182)

2

0 references

N Roy

3

0 references

M Talajic

4

0 references

D Roy

5

0 references

S Plante

6

0 references

J Turgeon

American Journal of Cardiology

7

0 references

language of work or name

English

0 references

publication date

1 August 1999

0 references

published in

0 references

volume

84

0 references

issue

3

0 references

page(s)

345-7, A8-9

0 references

cites work

Hazards of postoperative atrial arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Atrial arrhythmias after cardiothoracic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Safety and efficacy of procainamide infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Effects of flecainide on the rate dependence of atrial refractoriness, atrial repolarization and atrioventricular node conduction in anesthetized dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Efficacy of intravenous propafenone for the acute management of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Randomized placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900292-1